Last $93.57 USD
Change Today +0.77 / 0.83%
Volume 723.2K
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter R. Mueller Ph.D.

Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of The Scientific Advisory Board, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 2 different industries.

See Board Relationships
57$4,176,149
As of Fiscal Year 2013

Background*

Dr. Peter Mueller serves as Senior Vice President of Research and Development of Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Mueller has been the Chief Scientific Officer and Executive Vice President of Global Research & Development at Vertex Pharmaceuticals Inc. since July 21, 2003 and May 2009 respectively. In this role, Dr. Mueller is responsible for Vertex's research and drug discovery activities and directs research strategy across the Vertex Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Director

Education*

PhD
University of Mainz, Germany
Unknown/Other Education
Albert Einstein University of Ulm Germany
PhD
Albert Einstein University of Ulm Germany

Other Affiliations*

Annual Compensation*

Salary$619,846
Total Annual Compensation$619,846

Stock Options*

Restricted Stock Awards$544,988
All Other Compensation$12,675
Exercised Options167,300
Exercised Options Value$8,333,096
Exercisable Options733,271
Exercisable Options Value$28,266,246
Unexercisable Options191,604
Unexercisable Options Value$5,009,556
Total Value of Options$41,608,898
Total Number of Options1,092,175

Total Compensation*

Total Annual Cash Compensation$1,269,521
Total Short Term Compensation$619,846
Other Long Term Compensation$557,663
Total Calculated Compensation$4,176,149
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $93.57 USD +0.77

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
$1.1M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.